Literature DB >> 29429843

Invasive "in the cath-lab" assessment of myocardial ischemia in patients with coronary artery disease: When does the gold standard not apply?

Stefano Benenati1, Giovanni Luigi De Maria1, Roberto Scarsini2, Italo Porto3, Adrian P Banning4.   

Abstract

International guidelines recommend that revascularization for coronary artery disease (CAD) should be guided by evidence of myocardial ischemia. Fractional flow reserve (FFR) and instantaneous free wave ratio (iFR) are the main invasive indices for assessing the ischemic potential of angiographically intermediate coronary stenosis as a large body of evidence supports their routine application. Both indices have been tested and validated in patients with isolated stable CAD, but notably their application outside this specific context is a matter of debate and investigation. In the present review we aim to look into the available evidence about the reliability and feasibility of FFR and iFR in clinical contexts different from stable angina where these techniques have been validated. We aim to shed light on which technique can be used to invasively assess ischemia when an angiographic moderate coronary stenosis is observed in a clinical setting other than isolated stable CAD.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute coronary syndrome; Aortic stenosis; Chronic kidney disease; Chronic total occlusion; Diabetes; Fractional flow reserve; Instantaneous free wave ratio

Mesh:

Year:  2018        PMID: 29429843     DOI: 10.1016/j.carrev.2018.01.005

Source DB:  PubMed          Journal:  Cardiovasc Revasc Med        ISSN: 1878-0938


  1 in total

1.  Physiological Pattern of Disease Assessed by Pressure-Wire Pullback Has an Influence on Fractional Flow Reserve/Instantaneous Wave-Free Ratio Discordance.

Authors:  Takayuki Warisawa; Christopher M Cook; James P Howard; Yousif Ahmad; Shunichi Doi; Masafumi Nakayama; Sonoka Goto; Yohei Yakuta; Kenichi Karube; Matthew J Shun-Shin; Ricardo Petraco; Sayan Sen; Sukhjinder Nijjer; Rasha Al Lamee; Yuki Ishibashi; Hisao Matsuda; Javier Escaned; Carlo di Mario; Darrel P Francis; Yoshihiro J Akashi; Justin E Davies
Journal:  Circ Cardiovasc Interv       Date:  2019-05       Impact factor: 6.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.